Casa
scp 666 1/2 j

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years

Por um escritor misterioso

Descrição
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Frontiers Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
IJMS, Free Full-Text
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Frontiers Cannabis Therapeutics and the Future of Neurology
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Pharmacognosy and Effects of Cannabinoids in the Vascular System
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
What is CBD? - THCA Flower, Delta 9
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Modulation of the Endocannabinoid System in Cardiovascular Disease
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
New approaches and challenges to targeting the endocannabinoid system
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
American Society for Pharmacology and Experimental Therapeutics - ASPET on LinkedIn: #neurodegenerative #pharmacologicalreviews #pharmacology
de por adulto (o preço varia de acordo com o tamanho do grupo)